期刊文献+

SPIO增强MRI对兔肝脏微小肿瘤检出的研究 被引量:3

SPIO-enhanced MRI evaluation of rabbit bearing VX2 micro-hepatoma
下载PDF
导出
摘要 目的探讨超顺磁性氧化铁(SPIO)增强MR不同序列成像对兔VX2肝微小肿瘤病灶的检出率.方法 15只新西兰大白兔肝内种植VX2肿瘤,分别在种植肿瘤后7天、14天行MR SE T1WI、FSE T2WI、GRE T2*WI、GRE T1WI平扫和SPIO增强扫描,记录不同检查序列所显示的肿瘤数目,比较显示率,确定SPIO增强MRI最佳扫描参数.结果 15只兔肝内种植VX2肿瘤后共有15个肿瘤生长,成功率100%.种植后7天肿瘤<5 mm,SPIO增强序列GRE T2*WI、GRE T1WI可显示所有的肿瘤病灶,显示率为100%,明显优于MRI平扫,SPIO增强SE T1WI及FSE T2WI序列,GRE T2*WI序列有更好的肿瘤-肝实质信号对比.14天后,肿瘤生长到1~2 cm, 除GRE T2*WI序列平扫显示率增加外,其他各检查方法对病灶的显示没有明显的差异.结论 SPIO增强MRI的GRE T2*WI、GRE T1WI序列对兔肝脏VX2微小肿瘤具有同样的高检出率,进行SPIO肝脏增强MRI检查时,GRE T2*WI序列是首选序列. Objective To investigate the value of superparamagnetie iron oxide (SPIO) enhanced MRI with different sequences in detection of rabbit bearing VX2 micro-hepatoma. Methods Plain and SPIO-enhanced MRI were performed for all rabbits bearing VX2 tumor in the liver with the sequences of SE T1WI, FSE TSWI, GRE T2 WI and GRE T1WI. Microhepatoma was determined at different sequences and the tumor detectability was statistically analyzed respectively. Results Fifteen tumors grew from 3 mm to 5 mm in diameter with success rate of 100% at 7 days after the implantation. Total 15 tumors were depicted by GRE T2· WI and GRE T1WI. There was markedly statistical difference (P〈0.01) compared with other sequences. Fourteen days later, tumors grew to 1-2 cm in diameter. Apart from GRE T2 ·WI without SPIO enhancement, the rest of imaging modality had the same detectability of tumors (P〉0.05). Conclusion SPIO-enhaneed MRI can significantly increase the detectability of VX2 micro-tumors in rabbit livers and GRE T2 · WI is the best sequence in depicting hepatic micro-tumors.
出处 《中国医学影像技术》 CSCD 北大核心 2005年第11期1648-1651,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金资助(30170286)
关键词 超顺磁性氧化铁 动物 实验 VX2肿瘤 磁共振成像 Superparamagnetic iron oxide Animals, laboratory VX2 tumor Magnetic resonance imaging
  • 相关文献

参考文献11

  • 1Kim YK, Kim CS, Lee YH. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas[J]. AJR,2004,182(5):1217-1223.
  • 2Takahama K, Amano Y, Hayashi H. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging[J]. Abdom Imaging, 2003,28(4):525-530.
  • 3Kwak HS, Lee JM, Kim CS. Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography[J]. Eur Radiol,2004,14(3):447-457.
  • 4Lee JM, Kim CS, Youk JH. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging[J]. Korean J Radiol,2003,4(1):9-18.
  • 5Vogl TJ, Schwarz W, Blume S. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US[J]. Eur Radiol,2003,13(2):262-272.
  • 6刘岘,许乙凯,黄其鎏,吴元魁.使用SPIO对大鼠肝癌模型进行MR增强显像的实验研究[J].第一军医大学学报,2002,22(12):1061-1065. 被引量:2
  • 7Hahn PF, Saini S. Liver-specific MR imaging contrast agents[J]. Radiol Clin North Am,1998,36(2):287-297.
  • 8Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions[J]. Eur Radiol,1998,8(7):1198-1204.
  • 9王莉,田建明,陆建平,王飞,刘崎,曾浩,陈爱华,金爱国,龚建国,郝强,袁敏,陶文照.大鼠种植型肝癌的超顺磁性氧化铁磁共振增强实验研究[J].中华放射学杂志,2000,34(12):805-810. 被引量:10
  • 10Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions[J]. Radiology,1995,196(2):481-488.

二级参考文献17

  • 1杨继金,朱永法.大白鼠转移性肝癌模型的制作[J].中华放射学杂志,1993,27(2):122-123. 被引量:43
  • 2Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR Imaging of liver and spleen: first experience in human with a new superpara magnetic iron oxide [J]. J Magn Reson Imaging, 1994, 4 (5): 659-68.
  • 3Van Beers B, Gallez B, Pringot J. Contrast-enhanced MR imaging of the liver[J]. Radiology, 1997, 203(2): 297-306.
  • 4Oudkerk M, Van Den Heuvel AG, Wielopolski PA, et al. Hepatic le sions: detection with Ferumoxide-enhanced T1-weighted MR imaging[J]. Radiology, 1997, 203 (2): 449-56.
  • 5Mayo-Smith W, Saini S, Slater G, et al. MR contrast material for vascular enhancement: value ofsuperparamagnetic iron oxide [J].Am J Roentgenol, 1996, 166 (1): 73-7.
  • 6Van Gansbeke D, Metens TM, Matos C, et al. Effects of AMI-25 on liver vessels and tumors on T1-weighted turbo-field-echo images: implications for tumor characterization [ J ]. J Magn Resont Imaging, 1997, 7 (3): 482-9.
  • 7Shamsi K, Balzer T, Saini S, et al. Superparamagnetic iron oxide panicles (SH U 555A): evaluation of efficacy in three doses for hep atic MR imaging[J]. Radiology, 1998, 206 (2): 365-71.
  • 8Mutakami T, Kuroda C, Marukawa T, et al. Regenerating nodules of hepatic cirrhosis: MR findings with pathologic correlation [J]. Am J Roentgenol, 1990, 154 (3): 505-7.
  • 9Klimek F, Moore MA, Schneider E, et al. Histochemical and micro biochemical demonstrations of reduced pyruate kinase activity in thioacetamide-induced neoplastic nodules of rat liver [J]. Histochemistry, 1988, 90 (1): 37-42.
  • 10Kreft B, Block W, Dombrowski F, et al. Diagnostic value of a super paramagnetic iron oxide in MR imaging of chronic liver disease in a animal model[J]. Am J Roentgenol, 1998, 170 (3): 661-8.

共引文献10

同被引文献21

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部